1. Home
  2. SPRU vs AYTU Comparison

SPRU vs AYTU Comparison

Compare SPRU & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spruce Power Holding Corporation

SPRU

Spruce Power Holding Corporation

HOLD

Current Price

$1.46

Market Cap

30.0M

ML Signal

HOLD

Logo Aytu BioPharma Inc.

AYTU

Aytu BioPharma Inc.

HOLD

Current Price

$2.01

Market Cap

27.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPRU
AYTU
Founded
2008
N/A
Country
United States
United States
Employees
4
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.0M
27.4M
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
SPRU
AYTU
Price
$1.46
$2.01
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $9.67
AVG Volume (30 Days)
★ 155.0K
42.3K
Earning Date
11-10-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 62.30
N/A
EPS
★ 0.02
N/A
Revenue
$23,194,000.00
★ $27,632,080.00
Revenue This Year
N/A
$17.96
Revenue Next Year
N/A
$27.98
P/E Ratio
$73.50
★ N/A
Revenue Growth
48.68
★ 277.47
52 Week Low
$1.46
$1.80
52 Week High
$6.75
$3.07

Technical Indicators

Market Signals
Indicator
SPRU
AYTU
Relative Strength Index (RSI) 32.80 43.11
Support Level N/A $1.89
Resistance Level $1.90 $2.34
Average True Range (ATR) 0.08 0.08
MACD -0.02 -0.01
Stochastic Oscillator 0.00 27.40

Price Performance

Historical Comparison
SPRU
AYTU

About SPRU Spruce Power Holding Corporation

Spruce Power Holding Corp is an owner and operator of distributed solar energy assets across the United States (the U.S.), offering subscription-based services to home solar assets and customer contracts, making renewable energy more accessible to everyone. The Company's customers are homeowners and the Company's core solar service offerings generate revenues through, the sale of electricity generated by its home solar energy systems to homeowners, third-party contracts to sell solar renewable energy credits (SRECs) generated by the solar energy systems for fixed prices and the servicing of those agreements for other institutional owners of home solar energy systems.

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

Share on Social Networks: